| Cite this article: |
| WANG Kaiyun,PENG Xiaoxing,REN Dequan,HE Yueyi,HUANG Hua,HAN Pengfei,DENG Duping,SU Long.Clinical curative effect of continuous epidural analgesia combined with Shufeng Jiedu Decoction in herpes zoster neuralgia[J].Journal Of Pharmaceutical Research,2026,45(9):1065-1071[Click to copy] |
|
| 摘要: |
| 目的 探究持续硬膜外神经阻滞(CEA)联合舒风解毒汤治疗带状疱疹(HZ)神经痛患者的临床疗效。方法 前瞻性选取186例HZ神经痛患者,按随机数字表分为A组(CEA+舒风解毒汤)、B组(CEA)、C组(舒风解毒汤)各62例,疗程4周,随访3个月。比较3组的疗效、免疫功能、疼痛介质与炎症因子[神经肽P物质(SP)、β-内啡肽(β-EP)、神经激肽(NK)-1、干扰素(IFN)-γ、白细胞介素-10(IL-10)、IL-2]、疼痛相关指标、安全性及后遗神经痛发生率。结果 治疗4周后,A组疗效高于B、C组(P<0.05);A组CD3+、CD4+、CD4+/CD8+、β-EP、IFN-γ、IL-2水平高于B、C组,CD8+、SP、NK-1、IL-10水平低于B、C组(P<0.05);A组各时间点视觉模拟评分、24 h爆发痛次数、补救镇痛率及睡眠质量评分低于B、C组,镇痛满意度高于B、C组(P<0.05);3组不良反应无显著差异(P>0.05);随访3月,A组后遗神经痛发生率低于B、C组(P<0.05)。结论 CEA联合舒风解毒汤治疗可有效改善HZ神经痛患者的免疫状态,调控疼痛与炎症因子,减轻疼痛,降低后遗神经痛风险,且安全性好。 |
| 关键词: 带状疱疹神经痛 持续硬膜外神经阻滞 舒风解毒汤 疗效 疼痛介质 |
| DOI:10.13506/j.cnki.jpr.2026.09.016 |
| 基金项目:眉山市科技指导性计划项目(No.2024KJZD095) |
|
Received Date:March 18, 2026
Revision Date:April 22, 2026
Publication Date:September 30, 2026
|
|
| Clinical curative effect of continuous epidural analgesia combined with Shufeng Jiedu Decoction in herpes zoster neuralgia |
| WANG Kaiyun1,PENG Xiaoxing1,REN Dequan1,HE Yueyi1,HUANG Hua1,HAN Pengfei1,DENG Duping1,SU Long2 |
| (1.Meishan Hospital of Traditional Chinese Medicine,Meishan 620000,China;2.The Third People's Hospital of Renshou County,Meishan 620000,China) |
| Abstract: |
| Objective To explore clinical curative effect of continuous epidural analgesia (CEA) combined with Shufeng Jiedu Decoction in patients with herpes zoster (HZ) neuralgia.Methods According to random number table method, 186 patients with HZ neuralgia were prospectively enrolled and divided into group A (CEA+Shufeng Jiedu Decoction), group B (CEA) and group C (Shufeng Jiedu Decoction, n=62), 62 cases/group. All were treated for 4 weeks and followed up for 3 months. Curative effect, immune function, pain mediators and inflammatory factors [Neuropeptide substance P (SP), β-endorphin (β-EP), neurokinin (NK)-1, interferon (IFN) -γ, interleukin-10(IL-10), IL-2], pain-related indexes, safety and incidence of postherpetic neuralgia were compared among the three groups.Results After 4 weeks of treatment, curative effect of group A was better than that of groups B and C (P<0.05). Compared with groups B and C, levels of CD3+, CD4+, CD4+/CD8+, β-EP, IFN-γ and IL-2 were higher, while levels of CD8+, SP, NK-1 and IL-10 were lower in group A (P<0.05). Compared with groups B and C, scores of visual analogue scale (VAS) at different time points, frequency of 24 h breakthrough pain, remedial analgesia rate and score of sleep quality were lower, while analgesia satisfaction was higher in group A (P<0.05). There was no significant difference in adverse reactions among the three groups (P>0.05). After 3 months of follow-up, incidence of postherpetic neuralgia in group A was lower than that in groups B and C (P<0.05). Conclusion CEA combined with Shufeng Jiedu Decoction can effectively improve immune status, regulate pain and inflammatory factors, relieve pain and reduce the risk of postherpetic neuralgia in patients with HZ neuralgia, which has good safety. |
| Key words: Herpes zoster neuralgia Continuous epidural analgesia Shufeng Jiedu Decoction Curative effect Pain mediator |